Literature DB >> 10092069

Culture characterization of differentiated high endothelial venule cells from human tonsils.

E S Baekkevold1, F L Jahnsen, F E Johansen, O Bakke, G Gaudernack, P Brandtzaeg, G Haraldsen.   

Abstract

High endothelial venules (HEV) are specialized vessels that support abundant lymphocyte emigration from peripheral blood into secondary lymphoid organs. HEV endothelial cells (HEVEC) exhibit particular structural and functional features, including secretion of the HEV-specific extracellular matrix protein hevin and an array of uniquely glycosylated counter-receptors for L-selectin expressed on lymphocytes. These ligands are collectively called the peripheral lymph node addressin (PNAd), originally defined by the monoclonal antibody MECA-79. PNAd expression was used to purify HEVEC by positive immunoselection from enzyme-digested human tonsils after negative immunoselection for other cells. Purified HEVEC maintained secretion of hevin and homogenous expression of intercellular adhesion molecule (ICAM)-1 (CD54), ICAM-2 (CD102), and CD31, at high levels following 8 days in culture. Expression of functional PNAd was maintained during the first 4 to 5 days of culture but decreased gradually and disappeared on day 8, while the expression of CD34 remained strong. However, the CD34 glycoform shifted toward the in situ phenotype of flat-walled vessels, suggesting that the observed loss of L-selectin binding determinants and MECA-79 antigen was due to down-regulation of the glycosyl- and sulfo-transferases essential for their expression. Our rapid and reproducible method to establish HEVEC cultures provides a useful mechanistic tool for identification of the factors that induce and maintain the HEV phenotype, as well as a source for isolation of HEV-specific genes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10092069

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  7 in total

1.  Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules.

Authors:  Espen S Baekkevold; Myriam Roussigné; Takeshi Yamanaka; Finn-Eirik Johansen; Frode L Jahnsen; François Amalric; Per Brandtzaeg; Monique Erard; Guttorm Haraldsen; Jean-Philippe Girard
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

2.  Heterogeneity of endothelial cells: the specialized phenotype of human high endothelial venules characterized by suppression subtractive hybridization.

Authors:  J P Girard; E S Baekkevold; T Yamanaka; G Haraldsen; P Brandtzaeg; F Amalric
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

3.  Molecular cloning and functional analysis of SUT-1, a sulfate transporter from human high endothelial venules.

Authors:  J P Girard; E S Baekkevold; J Feliu; P Brandtzaeg; F Amalric
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

4.  Comprehensive analysis of lymph node stroma-expressed Ig superfamily members reveals redundant and nonredundant roles for ICAM-1, ICAM-2, and VCAM-1 in lymphocyte homing.

Authors:  Rémy T Boscacci; Friederike Pfeiffer; Kathrin Gollmer; Ana Isabel Checa Sevilla; Ana Maria Martin; Silvia Fernandez Soriano; Daniela Natale; Sarah Henrickson; Ulrich H von Andrian; Yoshinori Fukui; Mario Mellado; Urban Deutsch; Britta Engelhardt; Jens V Stein
Journal:  Blood       Date:  2010-04-15       Impact factor: 22.113

5.  Autotaxin, an ectoenzyme that produces lysophosphatidic acid, promotes the entry of lymphocytes into secondary lymphoid organs.

Authors:  Hidenobu Kanda; Rebecca Newton; Russell Klein; Yuka Morita; Michael D Gunn; Steven D Rosen
Journal:  Nat Immunol       Date:  2008-03-09       Impact factor: 25.606

Review 6.  High Endothelial Venules: A Vascular Perspective on Tertiary Lymphoid Structures in Cancer.

Authors:  Gerlanda Vella; Sophie Guelfi; Gabriele Bergers
Journal:  Front Immunol       Date:  2021-08-17       Impact factor: 7.561

Review 7.  Understanding high endothelial venules: Lessons for cancer immunology.

Authors:  Ann Ager; Michael J May
Journal:  Oncoimmunology       Date:  2015-05-07       Impact factor: 8.110

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.